TRanSLIT Results Presented at BE-PRECISE 2024 in Antwerp

During the first edition of the Belgian Precision and Personalized Oncology Meeting BE-PRECISE in Antwerp, Belgium, PhD student Selina Mader presented a poster presentation entitled “ROBO1 Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma”, putting her results of this TRanSLIT project in the picture.

Targeting ROBOs and SLIT guidance cues
in the immune-suppressive stromal context
of pancreatic cancer